
纤维肌痛、肠易激综合征、慢性疲劳综合征……这些病没有靶点,没有特效药,却真实折磨着无数患者。《大西洋月刊》哥伦比亚大学医学教授 Jason Liebowitz 揭示:现代医学的「魔法子弹」框架,正在面对一道它本就无力穿越的裂缝。本期附完整中英对照译文、10个核心词汇及两段长难句语法拆解。
"You're the eighth rheumatologist that I've seen," the patient told me. She ticked off her symptoms—pain, fatigue, and what she described as a sense of brain fog—which she'd lived with for years. Some doctors had no answers for her; others had said that she likely had fibromyalgia, a poorly understood pain-processing condition, and that they could do little to help. She began to cry, and I began to sweat.
My medical training had prepared me for seemingly everything—diagnosing heart attacks, treating life-threatening infections—but not for this kind of problem. I knew the technical definition of fibromyalgia, but my confidence in making the diagnosis correctly was exceedingly low: The disease can cause the symptoms my patient described but cannot be proven by lab or imaging studies. And even if fibromyalgia was the cause of her suffering, I had few concrete solutions to offer her.
Modern medicine is excellent at delivering treatments that precisely target the biological cause of a disease and produce clear, measurable improvement. The promise of such magic bullets shapes both doctors' training and patients' expectations. But for some of the most disabling conditions physicians treat today, no magic bullet exists, and doctors often struggle to identify what it is, exactly, that they're shooting at.
Illnesses such as fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome (also known as myalgic encephalomyelitis, or ME/CFS) rarely reveal a single malfunctioning molecule or damaged organ. In such cases, the best medicine can offer is often a patchwork of modestly effective medications and nonpharmacological interventions such as cognitive behavioral therapy, exercise, and tai chi.
The concept of the "magic bullet" arrived at exactly the right moment. The German physician Paul Ehrlich first came up with the metaphor in the early 20th century, when infectious disease was the leading cause of death worldwide. Ehrlich imagined a medicine that could act like a perfectly aimed projectile, striking a disease-causing organism while leaving the rest of the body unharmed.
But not all diseases cooperate with this framework. Fibromyalgia, for instance, likely arises from abnormal pain processing in the nervous system rather than tissue damage; research studies have shown that, when exposed to the same stimuli, patients with fibromyalgia exhibit greater activation in brain regions associated with pain than healthy individuals.
"The brain is not the origin of the problem, but it is the organ that's ultimately affected," Braden Kuo, the chief of digestive and liver diseases at Columbia University's Irving Medical Center, told me.
"Patients come to the doctor expecting their suffering to be translated into the language of objectivity, but that's just not possible for these conditions," Kaplan told me. Instead, patients are left trying to understand how their symptoms can be so intense even though their lab and imaging results appear "normal."
For some conditions, a discrete biological target and its magic bullet may exist, even if no one has found it yet. For decades, obesity—a complex, multifactorial disease shaped by genetics, environment, and behavior—was regarded as a pharmacological lost cause. Then came GLP-1 agonists, which, though not a cure-all, have driven dramatic weight loss for millions of patients.
But to meet the needs of patients with diseases such as fibromyalgia, IBS, chronic fatigue syndrome, and long COVID, medicine will need to loosen its reliance on the magic-bullet model. Not every illness will reveal a single molecular target, and not every treatment will come in the form of a pill or an injection. In many cases, the work of medicine will look less like marksmanship and more like navigation: helping patients experiment with therapies, manage symptoms, and rebuild a life shaped by chronic illness.

| 词汇/短语 | 音标 | 词性 | 释义 | 语境说明 |
|---|---|---|---|---|
| rheumatologist | /ˌruːmətəˈlɒdʒɪst/ | n. | 风湿病科医生 | 文中患者看过 8 位 rheumatologist,说明慢性疼痛疾病在医疗系统中辗转求医的普遍困境 |
| fibromyalgia | /ˌfaɪbrəʊmaɪˈældʒɪə/ | n. | 纤维肌痛 | 一种疼痛处理障碍,文章核心病例;注意:fibre(纤维)+ myalgia(肌肉疼痛)可拆解记忆 |
| brain fog | /breɪn fɒɡ/ | n. 短语 | 脑雾(认知模糊感) | 非正式医学术语,描述注意力涣散、思维迟缓的主观感受;六级/雅思高频词汇 |
| disabling | /dɪsˈeɪblɪŋ/ | adj. | 致残的,丧失行动能力的 | "some of the most disabling conditions",形容严重影响日常功能的疾病;比 serious 更精准 |
| patchwork | /ˈpætʃwɜːk/ | n./adj. | 拼凑物;拼凑起来的 | "a patchwork of modestly effective medications"——形容疗法东拼西凑,缺乏系统根基,是高级比喻用法 |
| nonpharmacological | /ˌnɒnˌfɑːməkəˈlɒdʒɪkl/ | adj. | 非药物的 | 对应 pharmacological(药物的);雅思/考研常见前缀 non- 词汇;CBT、运动、太极均属此类 |
| multifactorial | /ˌmʌltɪfækˈtɔːriəl/ | adj. | 多因素的 | 描述肥胖症等病因复杂、涉及多种变量的疾病,医学写作高频词 |
| pharmacological | /ˌfɑːməkəˈlɒdʒɪkl/ | adj. | 药理学的;药物治疗的 | "a pharmacological lost cause"——被视为药物治疗无望的领域;考研词汇 |
| psychosomatic | /ˌsaɪkəʊsəˈmætɪk/ | adj. | 心身性的,心理与躯体相互影响的 | 文中出现在 ME/CFS 的争议讨论中:"whether ME/CFS is a distinct biological disease or a psychosomatic problem";雅思高频 |
| pathophysiological | /ˌpæθəʊˌfɪziəˈlɒdʒɪkl/ | adj. | 病理生理学的 | "a discrete, demonstrable pathophysiological process"——指疾病背后可观测的生理机制;GRE/考研超纲但阅读中必知 |
原句:The disease can cause the symptoms my patient described but cannot be proven by lab or imaging studies.
原句:Not every illness will reveal a single molecular target, and not every treatment will come in the form of a pill or an injection. In many cases, the work of medicine will look less like marksmanship and more like navigation: helping patients experiment with therapies, manage symptoms, and rebuild a life shaped by chronic illness.
theatlantic.com
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.